Cargando…

Compliance and adherence of patients in the treatment of acute lymphoblastic leukemia

Detalles Bibliográficos
Autor principal:	Barr, Ronald Duncan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Associação Brasileira de Hematologia e Hemoterapia 2011
Materias:	Scientific Comments
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3415740/ https://www.ncbi.nlm.nih.gov/pubmed/23049287 http://dx.doi.org/10.5581/1516-8484.20110045

Ejemplares similares

The treatment of acute lymphoblastic leukemia has come a long way but the best is yet to come
por: Chauffaille, Maria de Lourdes Lopes Ferrari
Publicado: (2013)

Involvement of the cerebrospinal fluid cells in children with acute lymphoblastic leukemia: prognostic implications
por: Scrideli, Carlos Alberto
Publicado: (2012)

Qualitative polymerase chain reaction versus quantitative polymerase chain reaction for the detection of minimal residual disease in children with acute lymphoblastic leukemia()
por: Scrideli, Carlos Alberto, et al.
Publicado: (2015)

Comment on: Determination of serum levels of imatinib mesylate in patients with chronic myeloid leukemia: validation and application of a new analytical method to monitor treatment compliance
por: Simpson, David C
Publicado: (2013)

Pharmacogenetic testing for thiopurine drugs in Brazilian acute lymphoblastic leukemia patients
por: Suarez-Kurtz, Guilherme, et al.
Publicado: (2023)

Immunity against hepatitis B and measles vaccination after chemotherapy for acute lymphoblastic leukaemia in children: revaccination policy
por: Fioredda, Francesca
Publicado: (2012)

NOTCH-ing up nucleotide metabolism in T-cell acute lymphoblastic leukemia
por: Volk, Andrew
Publicado: (2021)

The expression of the CD56 antigen is associated with poor prognosis in patients with acute myeloid leukemia
por: Rego, Eduardo Magalhães
Publicado: (2011)

Scientific comment on: “Analysis of imatinib adherence in chronic myeloid leukemia: a retrospective study in a referral hospital in the Brazilian Amazon”. Who likes to take medicine forever?()
por: Bendit, Israel
Publicado: (2019)

Successful treatment of chronic myeloid leukemia with tyrosine kinase inhibitors goes beyond access to drugs
por: Conchon, Monika
Publicado: (2013)

Myeloid leukemia: are we getting better?()
por: Hamerschlak, Nelson
Publicado: (2015)

Compliance with a protocol for acute lymphoblastic leukemia in childhood
por: de Oliveira, Benigna Maria, et al.
Publicado: (2011)

Conditioning regimen using busulfan plus melphalan in hematopoietic stem cell transplantation: can this conditioning regimen be used in autologous or allogeneic transplantation for acute leukemia?
por: Lemoli, Roberto M., et al.
Publicado: (2011)

Genetic polymorphisms, chronic lymphocytic leukemia, and the future: are we there yet?
por: Caimi, Paolo F., et al.
Publicado: (2014)

Trends in management of acute lymphoblastic leukemia: Influence of insurance based healthcare and treatment compliance on the outcome of adolescents and adults with acute lymphoblastic leukemia
por: Arigela, Ravi Sankar, et al.
Publicado: (2016)

BCR-ABL rearrangement and HLA antigens: a possible link to leukemia pathogenesis and immunotherapy
por: Giunta, Marina, et al.
Publicado: (2012)

BCR-ABL1 level monitoring in chronic myeloid leukemia by real time polymerase chain reaction in Brazil – not so real()
por: Pagnano, Katia Borgia Barbosa
Publicado: (2017)

Optimizing Management of the Central Nervous System in Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Stem Cell Transplantation
por: Patel, Pranalee, et al.
Publicado: (2022)

Comparison of height and weight after 12 vs. 18 Gy cranial radiation therapy in pediatric acute lymphoblastic leukemia (ALL) patients
por: Chen, Albert C., et al.
Publicado: (2017)

Adherence to 6-Mercaptopurine in children and adolescents with Acute Lymphoblastic Leukemia
por: Alsous, Mervat, et al.
Publicado: (2017)

Febrile neutropenia studies in Brazil - treatment and cost management based on analyses of cases
por: Bellesso, Marcelo
Publicado: (2013)

Comment on: Consolidation treatment for high risk solid tumors in children with myeloablative chemotherapy and autologous hematopoietic progenitor stem cell transplantation
por: Kletzel, Morris
Publicado: (2013)

Bioengineering coagulation factors for improved hemophilia treatments(): Comment on: the mutation F309S increases FVIII secretion in human cell line
por: Hounkpe, Bidossessi Wilfried, et al.
Publicado: (2016)

Comment on: Bacteremia in pediatric patients with hematopoietic stem transplantation()
por: Macedo, Antonio Vaz de
Publicado: (2020)

Gene deletions of glutathione S-transferase and iron status in sickle cell patients
por: Zamaro, Paula Juliana Antoniazzo
Publicado: (2012)

Hematological and biochemical findings in patients with dengue fever: a current issue
por: da Cunha, Rivaldo Venâncio, et al.
Publicado: (2012)

Comment on: the relationship between splenomegaly and hematologic findings in patients with hepatosplenic schistosomiasis
por: Montenegro, Silvia Maria Lucena
Publicado: (2013)

Comment on: Relationship between splenomegaly and hematologic findings in patients with hepatosplenic schistosomiasis
por: Kaiser Junior, Roberto Luiz
Publicado: (2013)

Scientific comment on the theme of palliative care in pediatric hematological oncology patients()
por: Jankovic, Momcilo
Publicado: (2014)

Utility of the p53 mutant protein in patients with low-risk myelodysplastic syndrome
por: Yao, David C., et al.
Publicado: (2014)

Impact on patient of the detection of weakly expressed RhD antigens in blood donors()
por: Moraes-Souza, Helio, et al.
Publicado: (2015)

Comments on the clinical and laboratory characteristics of patients with dengue hemorrhagic fever manifestations and their transfusion profile
por: Lemes, Romélia Pinheiro Gonçalves
Publicado: (2014)

Patients with rheumatic diseases adhere to COVID-19 isolation measures more strictly than the general population
por: Hooijberg, Femke, et al.
Publicado: (2020)

Improving the Treatment of Acute Lymphoblastic Leukemia
por: Radadiya, Ashish, et al.
Publicado: (2020)

Comments on: Frequency of human platelet antigens in oncohematological patients with thrombocytopenia and the probability of incompatibility to platelet transfusions
por: de Paula, Erich Vinicius
Publicado: (2012)

The severity of illness and inflammatory markers cannot predict red blood cell alloimmunization in cancer patients
por: Castilho, Lilian
Publicado: (2013)

Comment on: Evaluation of erythrocyte and reticulocyte parameters as indicative of iron deficiency in patients with anemia of chronic disease()
por: Piva, Elisa
Publicado: (2015)

Comments on: molecular matching of red blood cells is superior to serological matching in sickle cell disease patients
por: Nance, Sandra Taddie, et al.
Publicado: (2013)

Comment on “Nutritional status of patients submitted to transplantation of allogeneic hematopoietic stem cells: a retrospective study”()
por: Schmidt, Erin M., et al.
Publicado: (2014)

Pyruvate kinase deficiency: novel mutations and a better understanding of the genotype-to-phenotype correlation in Brazilian patients()
por: Cançado, Rodolfo Delfini
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ro0t8iq7dmfcqmeubq5enhl0oe